In silico analysis showed that breast cancer patients exhibited higher expression levels of PNP. Similarly, elevated levels of PNP were observed in triple negative breast cancer subtypes compared to luminal subtypes, suggesting its association with breast cancer aggressiveness. The gene discussed is PNP; the disease is triple-negative breast carcinoma.